Charles City, IA, United States of America

Matthew Wendell Schiesher

This inventor holds 3 USPTO granted patents. Top assignee: Cambrex Charles City, Inc.. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Wendell Schiesher. Retrieved from https://idiyas.com/inventor/matthew-wendell-schiesher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Wendell Schiesher

Introduction

Matthew Wendell Schiesher is a notable inventor based in Charles City, IA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for preparing various amphetamine compounds. With a total of 3 patents to his name, Schiesher's work has implications for both medical and therapeutic applications.

Latest Patents

Schiesher's latest patents include innovative methods and compositions for preparing lisdexamfetamine and its salts. This invention provides detailed methodologies for synthesizing lisdexamfetamine from D-amphetamine. Another significant patent focuses on the preparation of amphetamine conjugates and their salts, including lisdexamfetamine and homoarginine-D-amphetamine. This patent outlines methods for creating an amphetamine conjugate from a chloramphetamine intermediate, showcasing Schiesher's expertise in chemical synthesis.

Career Highlights

Matthew Wendell Schiesher is currently associated with Cambrex Charles City, Inc., where he continues to advance his research and development efforts. His work at Cambrex has positioned him as a key player in the pharmaceutical industry, contributing to the development of important therapeutic agents.

Collaborations

Schiesher has collaborated with notable colleagues such as Jason Scott Douglas and Paul Alan Jass. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the research initiatives at Cambrex.

Conclusion

Matthew Wendell Schiesher's contributions to the field of pharmaceutical chemistry are noteworthy, with a focus on innovative methods for synthesizing amphetamine compounds. His work not only advances scientific knowledge but also has practical applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…